Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 21, 2026Canadian Journal of Urology

Understanding the utilization of genetic counseling and testing among patients with prostate cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

EMErnest MortonRLReza LahijiECElizabeth Chu

Discussion

Loading...

Member takes

Overview

Explores referral patterns and genetic testing outcomes in prostate cancer patients, highlighting significant barriers to utilization.

Key Points

  • The study aims to understand the patterns of referrals, genetic testing uptake, and outcomes for prostate cancer patients.
  • Reviewed patient records from Emory University from 2010 to 2022.
  • Identified men undergoing prostate biopsy and genetic counseling.
  • Assessed referrals against National Comprehensive Cancer Network (NCCN) guidelines.
  • Collected data on referral origin, testing completion rates, and results.
  • Used descriptive statistics to analyze findings.
  • Out of 6995 biopsies, only 70 patients consulted a genetic counselor.
  • Of those referred, 91.8% underwent genetic testing, with 62.2% receiving negative results.
  • 24.4% had variants of unknown significance (VUS), and 4.4% tested positive for pathogenic variants.
  • Referrals increased from 0 in 2015 to 12 in 2022, with urologists accounting for only 6.1% of referrals.

Cite This Study

Morton et al. (2026) studied this question.

synapsesocial.com/papers/69994bdd873532290d01ff02https://doi.org/10.32604/cju.2026.073853
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Improving Genetic Testing Uptake in Prostate Cancer: Outcomes From a Multidisciplinary Clinic Evaluation2026
  2. 2Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients2025 · 1 citations
  3. 3Identifying and characterizing the germinal genetic landscape of men with prostate cancer: A real-life, retrospective, multicenter study2026
  4. 4Abstract A139: Evaluating knowledge and practice patterns of prostate cancer germline testing among providers within a large health system2025
  5. 5Implementing comprehensive population-wide genomic testing in metastatic prostate cancer (mPCa): A real-world Canadian cohort study.2026